Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Reexamination Certificate
2007-05-29
2007-05-29
Salimi, Ali R. (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
C424S204100, C435S091100
Reexamination Certificate
active
10921868
ABSTRACT:
This invention relates to the development of a mammalian expression vector, under which expression of the structural genes of western equine encephalitis virus have been placed under the control of an eucaryotic promoter. When the recombinant vector is administered to mammalian cell culture or using a cell-free transcription/translation system, in vitro, authentic structural proteins of western equine encephalitis virus are produced as verified by reactivity with monoclonal antibodies developed to western equine encephalitis virus. When the recombinant DNA molecule is administered in vivo, a protective immune response is induced, thereby enhancing protection of the individual against subsequent infection by western equine encephalitis virus. In a similar manner, DNA vaccines to related alphaviruses (Venezuelan and eastern equine encephalitis viruses) could also be developed.
REFERENCES:
patent: 6261570 (2001-07-01), Parker et al.
Netolitzky et al, Journal of General Virology, Jan. 2000, vol. 81, pp. 151-159.
Bell et al, Journal of Virology, Feb. 1983, vol. 45, No. 2, pp. 708-714.
Pertmer et al, Vaccine, 1995, vol. 13, No. 15, pp. 1427-1430.
Wong et al, Vaccine, 1999, pp. 1788-1795.
Nagata et al. Vaccine, 2005, vol. 23, pp. 2280-2283.
Weaver et al., “Recombinational History of Molecular Evolution of Western Equine Encephalomyelitis Complex Alphaviruese,” Journal of Virology, vol. 71, No. 1.pp. 613-623 (1997).
Weaver et al., “A comparison of the Nuecleotide Sequences of Eastern and Western Equine Encephaloyeltiis Viruses with those of other Alphaviruses and Related RNA Viruses,” 197 Virology 375-390 (1993).
Hahn et al., “Western equine encephalitis virus is a recombinant virus,”.Proc. Natl. Acad. Sci. USA vol. 85, pp. 5997-6001 (Aug. 1988).
Nagata Leslie P.
Wong Jonathon P.
Rader & Fishman & Grauer, PLLC
Salimi Ali R.
The Minister of National Defence, Government of Canada
LandOfFree
DNA-based vaccine against the encephalitis alphaviruses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with DNA-based vaccine against the encephalitis alphaviruses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and DNA-based vaccine against the encephalitis alphaviruses will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3761093